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ABSTRACT
Mitomycin (MMC) has been associated with a
variety of complications, including
corneoscleral melt. We report the successful
repair of a scleral melt with a partial thickness
autologous scleral graft of the scleral melting. A
55-year-old male patient underwent pterygium
resection surgery and intraoperative MMC
application. The patient developed a deep
melting area that almost reached the choroid
layer at the nasal sclera. We repaired scleral
defect with a partial thickness autologous
scleral graft. Closure of an MMC-associated
scleral melting area with an autologous partial
thickness scleral graft is an effective and easy-to-
use method.
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INTRODUCTION
Mitomycin (MMC) application has been shown
to be effective in preventing recurrence in
pterygium surgery [1, 2]. MMC is an alkylating
agent that reduces pterygium recurrence by
inhibiting fibrovascular growth and has been
demonstrated to be a useful adjunct for this
surgery [3]. Unfortunately, MMC has also been
to be associated with a variety of complications,
including corneoscleral melt [3]. The scleral
defect must be covered with donor tissue to
prevent subsequent infection or perforation in
such cases. The materials used for this
complication include preserved sclera, cornea,
pericardium, dura or amniotic membrane [4].
We report the successful repair with a partial
thickness autologous scleral graft of the scleral
melting that developed in a patient who
underwent pterygium surgery with MMC.
CASE
A 55-year-old male patient underwent
pterygium resection surgery and intraoperative
MMC application at an external center for the
pterygium in his right eye, 6 months ago. The
patient developed a deep melting area that
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almost reached the choroid underlying the
nasal sclera during follow-up and was referred
to our clinic. The examination revealed full
visual acuity bilaterally with normal
biomicroscopy and retinal findings in the left
eye. A scleral melt area with a diameter of
0.5–0.75 cm and extending almost to the
choroid except for a thin membrane was
present approximately 1 cm away from the
limbus at the nasal section of the right eye.
Normal vascularization was severely decreased
in the defect starting from the limbus (Fig. 1). It
was decided to close the defect as the area was
open to trauma.
The conjunctiva in the defect region of the
right eye was dissected under retrobulbar
anesthesia. The edges of the scleral defect were
trimmed with a crescent knife to ensure donor
tissue as the graft site would adhere easily. In the
same eye, the conjunctiva and Tenon’s capsule
in the upper temporal region were then
dissected. A partial thickness scleral graft about
0.75–1.00 cm and suitable for the defect region
in size was then removed from the upper
temporal region with a 45 surgical knife.
Dissection was performed with utmost care in
order not to create scleromalacia in the area. The
Tenon’s capsule and conjunctiva in the region
where the graft was taken were primarily closed
with 8-0 vicryl. The removed graft was placed in
the appropriate position so as to close the defect
region and sutured with 8-0 vicryl. The Tenon’s
capsule and conjunctival tissue at the site of the
sclera defect were freed with blunt dissection and
sutured with 8-0 vicryl so as to close the entire
defect region. There were no complications and
surgery was ended with a subconjunctival
gentamicin and dexamethasone injection.
Postoperatively moxifloxacin, one drop, five
times a day and florometolon, one drop,
four times a day were started and the patient
was monitored. The patient had no symptoms
except for minimal stinging at the postoperative
first week. On examination, the conjunctiva was
hyperemic, the graft intact, the sutures
unharmed, visual acuity full, and the
intraocular pressure and retinal findings
normal. No complication was observed in the
postoperative first month. The visual acuity was
full, and the intraocular pressure and retinal
findings were normal. The patient had no
symptoms and the drops were stopped. In the
third postoperative month it was seen that the
defect had completely healed and was well
covered by a vascular conjunctiva. The region
providing the graft had also healed without any
complication. The visual acuity was full, and the
intraocular pressure and retinal findings were
normal (Fig. 2).
Fig. 1 Pre-operative appearance of the sclera melt in the
right eye after pterygium resection surgery and intraoper-
ative mitomycin
Fig. 2 Post-operative appearance of the autologous lamel-
lar scleral graft bed at 3 months
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Informed consent was obtained from the
patient for being included in the study.
DISCUSSION
MMC is used in many areas such as glaucoma
and pterygium surgery. MMC can cause serious
problems in tissues such as the cornea and
sclera if used for a longer duration than usual or
not sufficiently irrigated and removed
afterwards [3]. Our patient was operated on in
an external center so we did not know which
MMC regimen had been employed. Severe
damage occurred in the nasal region, affecting
the conjunctiva, Tenon’s capsule and sclera of
our case with sclera melting almost to the
choroid. In such cases, the choroid can be
ruptured by minimal trauma to the eye,
leading to vitreous loss and the risk of
infection, including endophthalmitis.
Amniotic membrane, fascia lata, pericardium,
dura mater, and corneal or scleral grafts can be
used to repair the defect [4, 5]. A scleral graft has
been used to treat perforated corneal ulcer,
scleral melting, or scleromalacia as it is strong,
flexible, easy to handle, and can be placed on
host sclera [6–8]. A scleral graft can also be used
in the cosmetic closure of an Ota nevus [9]. The
scleral graft can be obtained from another
donor or from the patient’s same or the other
eye [8]. We preferred partial thickness
autologous sclera because a relatively small
graft was required, removal of sclera from the
temporal site was straightforward and there was
no risk of rejection using this approach. The
upper temporal region was preferred as a site
distant from the earlier MMC exposure, where
scleral removal is easy. However, excessively
deep incisions during removal of the graft may
lead to choroidal and retinal damage or cause
later staphyloma formation. Scleral perforation
under the suture is another significant
complication that may occur. The repair did
not cause any preoperative or postoperative
complications in our case.
In conclusion, closure of an MMC-associated
scleral melting area with an autologous partial
thickness scleral graft is an effective and easy-to-
use method.
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